Floatz logo

Pevonedistat

B-Cell Prolymphocytic Leukemia

City of Hope Medical CenterPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the B-Cell Prolymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Sumithira Vasu
Phase 2BB
ETOPOSIDE
City of Hope Medical Center
Phase 2BB
Cyclophosphamide
Sumithira Vasu
Phase 2B
CYCLOSPORIN A
Ohio State University Comprehensive Cancer Center
Phase 2B
Evomela
Fred Hutchinson Cancer Center
Phase 2B

View all 18 →

Same molecule, other indications

Pevonedistat is also rated in:

chronic myelomonocytic leukemiaDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemiaDormant
BB
Indicative ·
66 / 100
View asset →
myelodysplastic syndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →